Is it appropriate to prescribe Ambien (zolpidem) on an as-needed basis for a resident with a substance use disorder in a skilled nursing facility?

Avoid Prescribing Ambien (Zolpidem) to Residents with Substance Use Disorder in Skilled Nursing Facilities

Do not prescribe Ambien (zolpidem) on an as-needed or scheduled basis for a resident with a history of substance use disorder in a skilled nursing facility. The FDA labeling explicitly warns that the risk of abuse and dependence increases with duration of treatment, and zolpidem has documented abuse potential, particularly in vulnerable populations 1, 2.

Primary Concerns in This Population

Addiction and Dependence Risk

• Zolpidem carries significant abuse and dependence potential in individuals with substance use disorders, with case reports documenting escalating doses from therapeutic levels to 60-900 mg/day 2.
• The FDA mandates that treatment should be as short as possible and that extended treatment should not occur without re-evaluation, as dependence risk increases with duration 1.
• Recent case series demonstrate severe withdrawal symptoms including rebound insomnia, social impairment, and craving when attempting to discontinue zolpidem in patients with dependence 2.

Complex Sleep Behaviors and Safety

• The FDA has issued a boxed warning for complex sleep behaviors including sleep-walking, sleep-driving, and engaging in activities while not fully awake, which can result in serious injuries and death 1.
• These behaviors may occur at recommended doses, with or without concomitant CNS depressants 1.
• In skilled nursing facilities specifically, benzodiazepines and sedative-hypnotics are associated with increased risk of both daytime and nighttime falls 3.

Limited Evidence in Nursing Home Settings

• Few studies have tested sleep medications specifically in nursing homes, and available evidence shows that residents on sedative-hypnotics performed more poorly on neurologic function tests and exhibited more daytime hypersomnolence 3.
• The relationship between sedative-hypnotic medications and adverse events including falls among nursing home residents requires clarification, as noted by the American Geriatrics Society 3.

Recommended Alternative Approach

First-Line Nonpharmacologic Interventions

• Implement bright light therapy in the morning, which has demonstrated beneficial effects on total sleep time at night in nursing home residents 3.
• Increase daytime physical activity and exercise, which has shown positive sleep effects in multiple studies of nursing home residents 3.
• Address environmental factors by reducing nighttime noise and light disruption, as half of nighttime awakenings are associated with these factors 3.
• Optimize sleep hygiene through multicomponent interventions that decrease daytime sleeping and time in bed during the day 3.

Address Underlying Contributors

• Systematically evaluate and treat pain, nocturia, gastroesophageal reflux, and respiratory symptoms that commonly interfere with sleep in nursing home residents 3.
• Review and adjust medications that may interfere with sleep, including diuretics, sympathomimetics, bronchodilators, stimulating antidepressants, and anticholinergics 3.
• Screen for and treat sleep apnea, which affects 32-70% of nursing home residents and has a strong relationship with dementia 3.

If Pharmacologic Treatment Is Absolutely Necessary

• Consider melatonin first, though evidence shows only isolated improvements in sleep quality based on caregiver ratings 3.
• Use sedating antidepressants such as trazodone or mirtazapine if depression or anorexia are present, as recommended by NCCN guidelines 3.
• Avoid benzodiazepines entirely in older patients and those with cognitive impairment due to decreased cognitive performance 3.

Critical Pitfalls to Avoid

• Never use "as-needed" dosing as a strategy to minimize risk—this does not reduce dependence potential and may actually facilitate drug-seeking behavior in patients with substance use disorders 1.
• Do not assume lower doses are safe in addiction-prone individuals, as case reports show dose escalation occurs regardless of starting dose 2.
• Avoid prescribing without addressing the underlying causes of insomnia, as the American Medical Directors Association recommends a 16-step approach emphasizing recognition, assessment, treatment, and follow-up 3.
• Do not overlook the high prevalence of psychiatric comorbidities in patients with substance use disorders, including eating disorders, depression, and personality disorders, which require integrated treatment 2, 4.

Special Considerations for Skilled Nursing Facilities

• SNF residents with substance use disorders face variable quality of care and may have difficulty accessing counseling and medical treatments depending on facility resources 5.
• Stigma and inadequate access to treatment are common barriers that must be addressed through staff education and integration of behavioral health services 5, 4.
• The SNF can be a positive site for recovery when appropriate supports are in place, including access to social work, activities, and counseling services 5.